Validation and a Couple Wins for VRX Stock
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) must be feeling some measure of validation as the U.S. Securities and Exchange Commission (SEC) has levied a $15.0 million fine at Allergan plc (NYSE:AGN) for failing to disclose news of friendlier bids during a hostile takeover attempt by Valeant.
VRX stock, meanwhile, has not benefited from the favorable ruling as the company has fallen seven percent over the past week.
Allergan is best known as the maker of the anti-aging.
Den vollständigen Artikel lesen ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) must be feeling some measure of validation as the U.S. Securities and Exchange Commission (SEC) has levied a $15.0 million fine at Allergan plc (NYSE:AGN) for failing to disclose news of friendlier bids during a hostile takeover attempt by Valeant.
VRX stock, meanwhile, has not benefited from the favorable ruling as the company has fallen seven percent over the past week.
Allergan is best known as the maker of the anti-aging.
Den vollständigen Artikel lesen ...